![Patrick Schnegelsberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick Schnegelsberg
Amministratore Delegato presso SynCardia Systems LLC
Posizioni attive di Patrick Schnegelsberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
SynCardia Systems LLC
![]() SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Amministratore Delegato | - | - |
Acorai AB
![]() Acorai AB Medical SpecialtiesHealth Technology Acorai AB is a Swedish medical device company founded in 2019. The company is based in Stockholm, Sweden. The company is developing a scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide. | Direttore/Membro del Consiglio | 01/04/2022 | - |
Storia della carriera di Patrick Schnegelsberg
Precedenti posizioni note di Patrick Schnegelsberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
Syntach AB
![]() Syntach AB Medical SpecialtiesHealth Technology Syntach AB is a Swedish company based in Lund that specializes in developing a revolutionary, minimally invasive long-term cardiac support device and mitral valve repair technology for people suffering from severe heart failure. Syntach has close links and extensive cooperation with various institutions at the University of Lund. The company is also developing a minimally-invasive device to correct mitral valve regurgitation, which can be used in combination with the cardiac support device or on a standalone basis. The company was founded in 2012 with the aim of creating an entirely new class of cardiac support devices to improve the care of the rapidly-growing number of people with heart failure. The company was founded by Tor Peters and Jan Otto Solem, who have been the CEOs since incorporation. | Amministratore Delegato | 31/01/2023 | 01/07/2023 |
Scandinavian Real Heart AB
![]() Scandinavian Real Heart AB Medical SpecialtiesHealth Technology Scandinavian Real Heart AB engages in the development of mechanical cardiac pumps. It offers an artificial heart that recreates the flow, pressure, and control of a pumping heart and can be used for patients awaiting heart transplants. The company was founded by Azad Najar, Gunnar Nihlén, and Said Zahrai in 1999 and is headquartered in Västerås, Sweden. | Direttore/Membro del Consiglio | 01/01/2022 | 07/06/2023 |
Independent Dir/Board Member | 01/01/2022 | 07/06/2023 | |
OCCLUTECH HOLDING AG | Amministratore Delegato | 01/03/2013 | - |
Direttore operativo | 01/07/2012 | 01/03/2021 | |
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Amministratore Delegato | 15/04/2006 | 01/11/2008 |
Formazione di Patrick Schnegelsberg
Harvard University | Graduate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Clark University | Undergraduate Degree |
Harvard Medical School | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Svezia | 4 |
Israele | 2 |
Posizioni
Chief Executive Officer | 4 |
Undergraduate Degree | 3 |
Director/Board Member | 2 |
Settori
Health Technology | 7 |
Consumer Services | 4 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
![]() | Health Technology |
Aziende private | 5 |
---|---|
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
SynCardia Systems LLC
![]() SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Health Technology |
Syntach AB
![]() Syntach AB Medical SpecialtiesHealth Technology Syntach AB is a Swedish company based in Lund that specializes in developing a revolutionary, minimally invasive long-term cardiac support device and mitral valve repair technology for people suffering from severe heart failure. Syntach has close links and extensive cooperation with various institutions at the University of Lund. The company is also developing a minimally-invasive device to correct mitral valve regurgitation, which can be used in combination with the cardiac support device or on a standalone basis. The company was founded in 2012 with the aim of creating an entirely new class of cardiac support devices to improve the care of the rapidly-growing number of people with heart failure. The company was founded by Tor Peters and Jan Otto Solem, who have been the CEOs since incorporation. | Health Technology |
Acorai AB
![]() Acorai AB Medical SpecialtiesHealth Technology Acorai AB is a Swedish medical device company founded in 2019. The company is based in Stockholm, Sweden. The company is developing a scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide. | Health Technology |
Occlutech Holding AG
![]() Occlutech Holding AG Medical SpecialtiesHealth Technology Occlutech Holding AG manufactures cardiac implant products. The firm?s products include Occlutech PLD, Occlutech Figulla Flex II, Sizing Occlutech ASD, Occlutech PDA Occluder, Occlutech Delivery Set and Occlutech Stiff Guide Wire. The company is headquartered in Schaffhausen, Switzerland. | Health Technology |